Irritable bowel syndrome is a chronic disorder characterized by episodes of constipation, diarrhea or both, as well as abdominal pain, bloating, and gas. It is more common in women than in men.
It is the second most common diagnostic diagnosis by gastrointestinal specialists. It also comes second after colds in the reasons for absenteeism.
Irritable bowel syndrome is a functional disorder, which means that it is not, as far as doctors know, linked to any disease or structural deformity. It is believed that a number of factors overlap and interact in it: infection, impaired communication between the brain and intestine, severe sensitivity to pain, hormones, allergies and emotional tension.
"People with irritable bowel syndrome who have symptoms of diarrhea are dominant or have a combination of irritable bowel syndrome. Doctors recommend a blood test to monitor abdominal cavity disease"
It is good, doctors say, that irritable bowel syndrome does not increase the risk of more serious conditions such as colic, ulcerative colitis, or colon cancer. However, there is no known cause of the disorder, which at best leads to discomfort and at worst to the appearance of harmful symptoms. The process of co-existence with irritable bowel syndrome is usually based on trial and error, which is challenging both patients and doctors. Any other medical conditions and many different treatments, most of which have not proven effective in the treatment of symptoms, including antibiotics, antipsychotics, antidepressants, food changes, relaxation methods, psychotherapy, as well as drugs to reduce constipation or diarrhea.
The guidelines offered by the American College of Gastroenterology (ACG) may help in finding effective strategies for co-existence with irritable bowel syndrome. The guidelines, prepared by a team of gastrointestinal specialists published in the January 2009 supplement of the US Journal of Digestive Diseases, restate the recommendations and guidelines published in 2002 that include the latest evidence on new treatments such as Probiotics On beneficial bacteria) and some medications for treating irritable bowel syndrome, in addition to ancient therapies.
According to the recommendations of 2009, the expanded tests (complete blood test, thyroid function test, stool screening for parasites, and abdominal tomography) are not necessary for people with normal Irritable Bowel Syndrome. Who have a family history of colorectal cancer, inflammatory bowel disease or celiac sprue disease who have no disturbing symptoms such as rectal hemorrhage, weight loss or iron deficiency anemia.
People with a nervous bowel syndrome who have diarrhea symptoms are dominant or have an irritable bowel syndrome. Doctors advise them to have a blood test to monitor abdominal cavity and should consider a lactose test if the lactose sensitivity is present, The new guidelines also simplify the language used to describe irritable bowel syndrome. The previous criteria, which included a list of special symptoms (such as defecation and repetition), limited the importance of irritable bowel monitoring according to experts. This disorder was now defined simply as pain or discomfort in the abdomen that is associated with changes in abdominal movement during A period of not less than three months.
Highlights of the disease:
The team of specialists reviewed 300 studies on the course of the natural irritable bowel syndrome and presented a series of new recommendations that were classified as severe. Or weak (2) with symptoms of the disease being as strong (A), moderate (B) or weak (C). The following are some of the most important points dealt with by these specialists:
Antidepressants: The short-term use of Rifaximin (Xifaxan)
Treatment that can not be absorbed (remaining inside the intestine) helps to reduce overall symptoms, especially bulging (grade 1B). However, it has not been shown to be safe and effective in the long term, nor has it been approved for treatment of irritable bowel syndrome.
The drug "rifaximine" is licensed to treat travel diarrhea with a dose of 200 milligrams (twice a day) for three days. Early tests of the drug were performed on patients with neuropathy who took large doses of it for a long time (400 mg, 2 to 3 times daily for 10 days or 555 mg daily for 14 days)
It should be noted that rifaxamine is very expensive while other antibiotics can perform an important negation for some patients at little cost.
Fiber Stool Capacitors:
Staphylococcus aureus, which contains a leaf plant, improves overall symptoms but wheat bran or corn bran was no better than placebo in the treatment of irritable bowel syndrome (grade 2C). The new guidelines did not discuss grain containing the tongue.
Drugs approved by the Food and Drug Administration for the treatment of irritable bowel syndrome:
The most recent antiretroviral drugs are "Lubiprostone" (Amitza), which is effective in reducing the overall symptoms of women who have a predominant vie